Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10016994
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10016994
Fusion event
HBV-PGM2L1 integration
Validated
No
Detection method
Capture-NGS platform
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2019
PubMed ID
30070724
Virus Sequence
Virus name
HBV
Subtype
B
Reference genome
NC_003977
Start
1823
End
1904
Integrated sequence
TTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATG
Host Sequence
Chromosome
chr11
Cytoband
q13.4
Reference genome
GRCh37/hg19
Start
74113839/74402794 (Hg38)
End
74113888/74402843 (Hg38)
Location type
Promoter
Fragile sites / regions
FRA11H
Target gene
PGM2L1
miRNAs that regulate target gene
hsa-mir-93-5p
;
hsa-mir-615-3p
;
hsa-mir-20a-5p
;
hsa-mir-106b-5p
;
hsa-mir-6780a-5p
;
hsa-mir-6779-5p
;
hsa-mir-3689c
;
hsa-mir-3689b-3p
;
hsa-mir-3689a-3p
;
hsa-mir-30b-3p
;
hsa-mir-1273h-5p
;
hsa-mir-6778-5p
;
hsa-mir-6832-5p
;
hsa-mir-1233-5p
;
hsa-mir-4451
;
hsa-mir-6799-5p
;
hsa-mir-6883-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-149-3p
;
hsa-mir-7106-5p
;
hsa-mir-6124
;
hsa-mir-3135a
;
hsa-mir-6831-5p
;
hsa-mir-3927-3p
;
hsa-mir-6856-5p
;
hsa-mir-4496
;
hsa-mir-6758-5p
;
hsa-mir-3910
;
hsa-mir-4796-3p
;
hsa-mir-548an
;
hsa-mir-548t-5p
;
hsa-mir-548az-5p
;
hsa-mir-4500
;
hsa-let-7d-5p
;
hsa-let-7e-5p
;
hsa-let-7f-5p
;
hsa-let-7g-5p
;
hsa-mir-98-5p
;
hsa-let-7i-5p
;
hsa-mir-4458
;
hsa-let-7c-5p
;
hsa-let-7b-5p
;
hsa-let-7a-5p
;
hsa-mir-323a-3p
;
hsa-mir-100-3p
;
hsa-mir-606
;
hsa-mir-6809-3p
;
hsa-mir-6833-3p
;
hsa-mir-4768-5p
;
hsa-mir-4753-3p
;
hsa-mir-6873-3p
;
hsa-mir-130b-5p
;
hsa-mir-6817-3p
;
hsa-mir-7110-3p
;
hsa-mir-7157-5p
;
hsa-mir-4310
;
hsa-mir-2114-3p
;
hsa-mir-6878-3p
;
hsa-mir-496
;
hsa-mir-5681b
;
hsa-mir-6744-3p
;
hsa-mir-4757-5p
;
hsa-mir-133a-5p
;
hsa-mir-6778-3p
;
hsa-mir-4774-5p
;
hsa-mir-3922-3p
;
hsa-mir-3176
;
hsa-mir-1976
;
hsa-mir-150-5p
;
hsa-mir-8073
;
hsa-mir-221-5p
;
hsa-mir-6747-3p
;
hsa-mir-6727-3p
;
hsa-mir-4722-3p
;
hsa-mir-660-3p
;
hsa-mir-5193
;
hsa-mir-186-3p
;
hsa-mir-6504-3p
;
hsa-mir-518e-3p
;
hsa-mir-518f-3p
;
hsa-mir-518d-3p
;
hsa-mir-518c-3p
;
hsa-mir-518b
;
hsa-mir-518a-3p
;
hsa-mir-3664-5p
;
hsa-mir-4743-3p
;
hsa-mir-4531
;
hsa-mir-6888-3p
;
hsa-mir-642a-5p
;
hsa-mir-6740-3p
;
hsa-mir-152-5p
;
hsa-mir-597-3p
;
hsa-mir-182-3p
;
hsa-mir-5703
;
hsa-mir-4516
;
hsa-mir-4434
;
hsa-mir-8082
;
hsa-mir-4534
;
hsa-mir-1273f
;
hsa-mir-6837-3p
;
hsa-mir-6754-3p
;
hsa-mir-412-3p
;
hsa-mir-3120-5p
;
hsa-mir-29b-1-5p
;
hsa-mir-6824-3p
;
hsa-mir-6764-3p
;
hsa-mir-2276-5p
;
hsa-mir-6892-3p
;
hsa-mir-183-5p
;
hsa-mir-27b-3p
;
hsa-mir-27a-3p
;
hsa-mir-19b-3p
;
hsa-mir-19a-3p
;
hsa-mir-519d-3p
;
hsa-mir-20b-5p
;
hsa-mir-17-5p
Nearest miRNA
hsa-mir-10392/Upstream/3461; hsa-let-7a-2/Downstream/317425;
Nearest TSS
ENST00000527297/Upstream/4321;
ENST00000530510/Downstream/52505;
Nearest CpG islands
None/Target,
chr11-CpG: 30/Upstream/3902
,
chr11-CpG: 50/Downstream/64287
Upstream sequence
gtgtgtggctgtgtatgttatctctgtgtctttgtgcctctgtgtgagctgtctgtaaatttgtgtgtgtgtatctgtgtctgtgttgtctgtgtgtgtg
Downstream sequence
ataatatatatatatGGGTATTGTTTGTACTATTTTTATTTTTGTAACTTTGACATCAtttttttcttttctttctttctttttttttgagactgggtcc
Target sequence
tgtatatattatatatattatgtatatataatatatattatgtatatat
Reference
Li, C. L., et al.Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region. Hepatology,2019, 69(2): 498-512.
Sample Information
×
Sample name
M17
Sample type
Tumor
Gender
Male
CpG Island Information
×
Download
Curate